These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 28007610)

  • 1. Structure, biochemistry, and biology of PAK kinases.
    Kumar R; Sanawar R; Li X; Li F
    Gene; 2017 Mar; 605():20-31. PubMed ID: 28007610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P21 activated kinases: structure, regulation, and functions.
    Rane CK; Minden A
    Small GTPases; 2014; 5():. PubMed ID: 24658305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rho family GTPase signaling through type II p21-activated kinases.
    Chetty AK; Ha BH; Boggon TJ
    Cell Mol Life Sci; 2022 Nov; 79(12):598. PubMed ID: 36401658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P21 activated kinase signaling in cancer.
    Rane CK; Minden A
    Semin Cancer Biol; 2019 Feb; 54():40-49. PubMed ID: 29330094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A tale of two Paks.
    Arias-Romero LE; Chernoff J
    Biol Cell; 2008 Feb; 100(2):97-108. PubMed ID: 18199048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of p21 Activated Kinase 1 (PAK1) in the invasion and motility of oral cancer cells.
    Parvathy M; Sreeja S; Kumar R; Pillai MR
    BMC Cancer; 2016 May; 16 Suppl 1(Suppl 1):293. PubMed ID: 27229476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling, Regulation, and Specificity of the Type II p21-activated Kinases.
    Ha BH; Morse EM; Turk BE; Boggon TJ
    J Biol Chem; 2015 May; 290(21):12975-83. PubMed ID: 25855792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The p21-activated kinases in neural cytoskeletal remodeling and related neurological disorders.
    Zhang K; Wang Y; Fan T; Zeng C; Sun ZS
    Protein Cell; 2022 Jan; 13(1):6-25. PubMed ID: 33306168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UnPAKing the class differences among p21-activated kinases.
    Eswaran J; Soundararajan M; Kumar R; Knapp S
    Trends Biochem Sci; 2008 Aug; 33(8):394-403. PubMed ID: 18639460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of p21-activated kinases (PAKs).
    Rudolph J; Crawford JJ; Hoeflich KP; Wang W
    J Med Chem; 2015 Jan; 58(1):111-29. PubMed ID: 25415869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of Rac/Cdc42/PAK pathway in cytoskeletal rearrangements.
    Szczepanowska J
    Acta Biochim Pol; 2009; 56(2):225-34. PubMed ID: 19513348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P21-activated kinase in inflammatory and cardiovascular disease.
    Taglieri DM; Ushio-Fukai M; Monasky MM
    Cell Signal; 2014 Sep; 26(9):2060-9. PubMed ID: 24794532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of PAK4 or PAK1 inhibits the proliferation of mutant KRAS colon cancer cells independently of RAF/MEK/ERK and PI3K/AKT signaling.
    Tabusa H; Brooks T; Massey AJ
    Mol Cancer Res; 2013 Feb; 11(2):109-21. PubMed ID: 23233484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAK signaling in oncogenesis.
    Molli PR; Li DQ; Murray BW; Rayala SK; Kumar R
    Oncogene; 2009 Jul; 28(28):2545-55. PubMed ID: 19465939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting group II PAKs in cancer and metastasis.
    Eswaran J; Soundararajan M; Knapp S
    Cancer Metastasis Rev; 2009 Jun; 28(1-2):209-17. PubMed ID: 19160016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of p-21-activated kinases in cancer progression.
    King H; Nicholas NS; Wells CM
    Int Rev Cell Mol Biol; 2014; 309():347-87. PubMed ID: 24529727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pak protein kinases and their role in cancer.
    Dummler B; Ohshiro K; Kumar R; Field J
    Cancer Metastasis Rev; 2009 Jun; 28(1-2):51-63. PubMed ID: 19165420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of p21-activated kinases in cardiovascular development and function.
    Kelly ML; Astsaturov A; Chernoff J
    Cell Mol Life Sci; 2013 Nov; 70(22):4223-8. PubMed ID: 23640572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAKs in human disease.
    Chan PM; Manser E
    Prog Mol Biol Transl Sci; 2012; 106():171-87. PubMed ID: 22340718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Group II p21-activated kinases as therapeutic targets in gastrointestinal cancer.
    Shao YG; Ning K; Li F
    World J Gastroenterol; 2016 Jan; 22(3):1224-35. PubMed ID: 26811660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.